ABSTRACT

Health workers are designated as a priority group for COVID-19 vaccine recipients because health workers work in health care facilities and public service workers are a high-risk group for contracting COVID-19. After giving the COVID-19 vaccine, it is possible to develop AEFI. This study was conducted to find out the description of the demographic status, comorbid diseases, and AEFI in health workers after the COVID-19 vaccine in RSUD Abdul Moeloek 2021. Because RSUD Abdul Moeloek is one of the local government referral general hospitals to handle COVID-19. Observational analysis using a cross-sectional method approach using a purposive sampling technique of 280 total samples. Data collection began in December 2021. This research was conducted at RSUD Abdul Moeloek in Bandar Lampung. Univariate data analysis test using SPSS 24. It is known that from 280 respondents, 24 people have not received the third dose of the vaccine, the most age who received the vaccine was the age of 26-35 years as many as 84 people (30%), and the most gender were women as many as 168 people (60%), health workers who did not have comorbidities as many as 267 people (95.4%), and the most common symptom of AEFI after the COVID-19 vaccine was a headache as many as 109 people (38.9%). After conducting the research, it was found that most of the health workers had received the complete vaccine up to the third dose, with the highest age being at the age of 26-35 years, being female. Almost all respondents do not have comorbidities and the symptoms of AEFI after the COVID-19 vaccine are headaches.

Keywords: COVID-19 Vaccine, Demography, AEFI

ABSTRAK

Tenaga kesehatan ditetapkan sebagai kelompok prioritas penerima vaksin COVID-19, dikarenakan tenaga kesehatan merupakan kelompok berisiko tinggi tertular COVID-19. Setelah pemberian vaksin COVID-19 dapat memungkinkan timbulnya KIPI. Maka dari itu penelitian ini di lakukan untuk mengetahui gambaran status demografi, penyakit komorbid dan KIPI pada tenaga kesehatan setelah vaksin COVID-19 di RSUD Abdul Moeloek tahun 2021. RSUD Dr. H. Abdul Moeloek merupakan salah satu rumah sakit umum daerah rujukan dari pemerintah setempat untuk menangani pasien COVID-19. Analitik observasional dengan menggunakan pendekatan metode cross sectional menggunakan teknik purposive sampling sebanyak 280 sampel keseluruhan. Pengambilan data dimulai pada bulan Desember 2021. Penelitian ini dilakukan di RSUD Abdul Moeloek Bandar Lampung. Analisis data univariat menggunakan SPSS 24. Didapatkan dari 280 orang responden penelitian, 24 orang belum vaksin dosis ketiga, usia terbanyak mendapat vaksin adalah usia 26-35 tahun sebanyak 84 orang (30%), jenis kelamin terbanyak adalah perempuan sebanyak 168 orang (60%), tenaga kesehatan yang tidak memiliki komorbid sebanyak 267 orang (95,4%), dan gejala KIPI pasca vaksin COVID-19 terbanyak adalah nyeri kepala sebanyak 109 orang (38,9%). Sebagian besar tenaga kesehatan telah mendapat vaksin lengkap sampai dosis ketiga, dengan usia terbanyak pada usia 26-35 tahun, berjenis kelamin perempuan. Hampir seluruh responden tidak memiliki komorbid dan gejala KIPI pasca vaksin COVID-19 yang paling banyak dirasakan adalah nyeri kepala.

Kata Kunci : Vaksin COVID-19, demografi, KIPI

Aditama, T. Y. (2021). COVID-19 dalam Tulisan Prof. Tjandra (O. D. Sampurno (ed.); 2nd ed.). Lembaga Penerbit Badan Penelitian dan Pengembangan Kesehatan (LPB).

Barbara, L., & Miriam, S. (2020). Safety Platform for Emergency Vaccines: Priority List of Adverse Events of Special Interest: COVID-19. December, V2.0.

Dahlan, M. S. (2017). Pintu Gerbang Memahami Statistik Metodologi Dan Epidemiologi Metode MSD M. Sopiyudin Dahlan. Sari Pediatri, 2(1), 2.

Fu, C., Wei, Z., Pei, S., Li, S., Sun, X., & Liu, P. (2020). Acceptance and preference for COVID-19 vaccination in health-care workers (HCWs). MedRxiv, 2962(548). https://doi.org/10.1101/2020.04.09.20060103

Kemenkes RI. (2021a). Buku Saku Tanya Jawab Seputar Vaksinasi COVID-19 (1st ed.). Kementerian Kesehatan Republik Indonesia.

Kemenkes RI. (2021b). Keputusan Menteri Kesehatan No. HK.01.07/MENKES/4638/2021 Tentang Petunjuk Teknis Pelaksanaan Vaksinasi Dalam Rangka Penanggulangan Pandemi COVID-19. Keputusan Menteri Kesehatan, 2021, 1–157. https://www.dinkes.pulangpisaukab.go.id/2021/05/21/keputusan-menteri-kesehatan-no-hk-01-07-menkes-4638-2021-tentang-juknis-pelaksanaan-vaksinasi-dalam-rangka-penanggulangan-pandemi-covid-19/

Kemenkes RI. (2021c). PMK No 10 Tahun 2021 Tentang Pelaksanaan Vaksinasi dalam Rangka Penanggulangan Pandemi Corona Virus Disease 2019 (COVID-19). Permenkes RI, 2019, 33. https://persi.or.id/wp-content/uploads/2021/02/pmk10-2021.pdf

Kemenkes RI. (2021d). Question ( Faq ) Pelaksanaan Vaksinasi Covid-. 2020, 1–16. https://kesmas.kemkes.go.id/assets/uploads/contents/others/FAQ_VAKSINASI_COVID__call_center.pdf

Kemenkes RI. (2021e). Vaksinasi COVID-19 Nasional. Https://Vaksin.Kemkes.Go.Id/. https://vaksin.kemkes.go.id/#/vaccines

Lidiana, E. H., Mustikasari, H., Pradana, K. A., & Permatasari, A. (2021). GAMBARAN KARAKTERISTIK KEJADIAN IKUTAN PASCA VAKSINASI COVID-19 PADA TENAGA KESEHATAN ALUMNI UNIVERSITAS ‘AISYIYAH SURAKARTA. Jurnal Ilmiah Kesehatan, 11(Juni), 11–17.

Marwan. (2021). Peran vaksin penanganan pandemi COVID19. Fakultas Kedokteran Universitas Mulawarman - RSU A. W. Sjahranie Samarinda, 1(covid). http://lp2m.unmul.ac.id/webadmin/public/upload/files/9584b64517cfe308eb6b115847cbe8e7.pdf

Masturoh, I. (2018). Metodologi Penelitian Kesehatan (N. Suwarno (ed.)). Kementerian Kesehatan Republik Indonesia.

Our World In Data. (2021). Coronavirus (COVID-19) Vaccinations Statistics and Research. Ourworldindata.Org/. https://ourworldindata.org/covid-vaccinations?country=OWID_WRL

Reiter, P. L., Pennell, M. L., & Katz, M. L. (2020). Acceptability of a COVID-19 vaccine among adults in the United States: How many people would get vaccinated? Vaccine, 38(42), 6500–6507. https://doi.org/10.1016/j.vaccine.2020.08.043

Rosidwikasari. (2017). Gambaran Kejadian Ikutan Pasca Imunisasi (Kipi) Campak Pada Anak Yang Memiliki Alergi Di Desa Suka Dame Kecamatan Silangkitang. Sumatera Utara University.

Trigo, J., García-Azorín, D., Sierra-Mencía, Á., Tamayo-Velasco, Á., Martínez-Paz, P., Tamayo, E., Guerrero, A. L., & Gonzalo-Benito, H. (2021). Cytokine and interleukin profile in patients with headache and COVID-19: A pilot, CASE-control, study on 104 patients. Journal of Headache and Pain, 22(1), 1–11. https://doi.org/10.1186/s10194-021-01268-w

Wang, J., Jing, R., Lai, X., Zhang, H., Lyu, Y., Knoll, M. D., & Fang, H. (2020). Acceptance of covid-19 vaccination during the covid-19 pandemic in china. Vaccines, 8(3), 1–14. https://doi.org/10.3390/vaccines8030482

WHO. (2020). Vaccines and immunization: What is vaccination? Www.Who.Int. https://www.who.int/news-room/q-a-detail/vaccines-and-immunization-what-is-vaccination?topicsurvey

WHO. (2022a). Modul 3 : Kejadian Ikutan Pasca Imunisasi.

WHO. (2022b). Tanya Jawab: Bagaimana cara kerja vaksin? WHO Indonesia. https://www.who.int/indonesia/news/novel-coronavirus/qa/qa-cara-kerja-vaksin